MX347754B - Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar. - Google Patents

Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar.

Info

Publication number
MX347754B
MX347754B MX2014002051A MX2014002051A MX347754B MX 347754 B MX347754 B MX 347754B MX 2014002051 A MX2014002051 A MX 2014002051A MX 2014002051 A MX2014002051 A MX 2014002051A MX 347754 B MX347754 B MX 347754B
Authority
MX
Mexico
Prior art keywords
probes
development
fluorescent probes
unbound bilirubin
labeled
Prior art date
Application number
MX2014002051A
Other languages
English (en)
Other versions
MX2014002051A (es
Inventor
Baolong Zhu
James Patrick Kampf
Alan Marc Kleinfeld
Andres Henry Huber
Thomas Kwan
Original Assignee
Alan Marc Kleinfeld
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alan Marc Kleinfeld filed Critical Alan Marc Kleinfeld
Publication of MX2014002051A publication Critical patent/MX2014002051A/es
Publication of MX347754B publication Critical patent/MX347754B/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/728Bilirubin; including biliverdin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • Y10T436/146666Bile pigment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

La presente invención se refiere a una composición que comprende (a) una sonda que se une a la bilirrubina pero no se une significantemente al ácido graso que comprende una muteína de proteína enlazadora de lípidos intracelulares (iLBP) etiquetada con un primer fluoróforo, en donde la muteína de iLBP corresponde a SEQ ID NO: 3 comprende una o más sustituciones de aminoácidos en posiciones seleccionadas del grupo que consiste en las posiciones 14, 18, 23, 25, 27, 31, 36, 38, 55, 60, 72, 73, 74, 78, 102, 104, 106, 115 y 117, y en donde el primer fluoróforo está unido a un residuo de lisina, el grupo amino de término N de la iLBP, o una substitución de cisteína, y (b) un segundo fluoróforo, en donde el segundo fluoróforo está libre en la solución o unido a una proteína que no se une a la bilurrubina, y en donde el primer fluoróforo y el segundo fluoróforo son capaces de la excitación en la misma longitud de onda, y en donde la longitud de onda de emisión del primer fluoróforo y el segundo fluoróforo es diferente, y en donde el segundo fluróforo no cambia su emisión en respuesta a la bilurribuna que se une a la muteína de iLBP.
MX2014002051A 2011-08-26 2012-08-24 Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar. MX347754B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161527849P 2011-08-26 2011-08-26
PCT/US2012/052395 WO2013032953A2 (en) 2011-08-26 2012-08-24 Development and use of fluorescent probes of unbound bilirubin

Publications (2)

Publication Number Publication Date
MX2014002051A MX2014002051A (es) 2014-09-12
MX347754B true MX347754B (es) 2017-05-11

Family

ID=47757131

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019010563A MX380526B (es) 2011-08-26 2012-08-24 Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar
MX2014002051A MX347754B (es) 2011-08-26 2012-08-24 Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2019010563A MX380526B (es) 2011-08-26 2012-08-24 Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar

Country Status (12)

Country Link
US (3) US9529003B2 (es)
EP (2) EP3598139A1 (es)
JP (3) JP6104913B2 (es)
CN (2) CN104220877B (es)
AU (3) AU2012300319B8 (es)
CA (1) CA2846106C (es)
CY (1) CY1122022T1 (es)
DK (1) DK2748615T3 (es)
ES (1) ES2733974T3 (es)
MX (2) MX380526B (es)
PT (1) PT2748615T (es)
WO (1) WO2013032953A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105073770B (zh) * 2012-11-16 2019-08-06 Iba股份有限公司 链霉亲和素突变蛋白及其使用方法
JP6444856B2 (ja) * 2013-02-28 2018-12-26 国立研究開発法人理化学研究所 蛍光特性を示す新規なポリペプチド、およびその利用
WO2015084894A1 (en) 2013-12-03 2015-06-11 Alan Kleinfeld Determination of the unbound free fatty acid profiles in biological and industrial specimens
US20160146838A1 (en) * 2014-11-20 2016-05-26 Jean Ronald Brisard System and method for ebola detection
CN106872379B (zh) * 2015-05-16 2019-08-27 深圳市启蒙智慧医疗科技有限公司 一种尿液成分测量分析仪
WO2018190357A1 (ja) * 2017-04-11 2018-10-18 国立研究開発法人産業技術総合研究所 レクチンの固定化方法
WO2019195317A1 (en) * 2018-04-03 2019-10-10 Neometrix Dx Methods and devices for assessing in vivo toxic levels of bilirubin and diagnosing increased risk of bilirubin neurotoxicity
CN111334079A (zh) * 2018-12-18 2020-06-26 中国科学院大连化学物理研究所 一种全光谱高亮度、高稳定性荧光染料及其合成和应用
AU2020340383A1 (en) * 2019-08-30 2022-04-14 Alan Marc Kleinfeld One step methods, kits, and systems for the measurement of concentrations of unbound bilirubin in biological fluids
CN111239094B (zh) * 2020-03-13 2022-08-26 河南中医药大学 一种碱性磷酸酶的灵敏检测方法
CN113238041B (zh) * 2021-01-13 2024-01-16 军事科学院军事医学研究院环境医学与作业医学研究所 一种基于β-环糊精修饰的免疫生物条形码增敏探针以及快速检测阿特拉津的方法
US11908583B2 (en) * 2022-05-02 2024-02-20 Kpn Innovations, Llc. Apparatus and method for determining toxic load quantifiers
CN120112542A (zh) * 2023-09-27 2025-06-06 京东方科技集团股份有限公司 针对亨廷顿舞蹈症的早期诊断的多肽探针和试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470714A (en) 1989-12-12 1995-11-28 Lidak Pharmaceuticals One-step free fatty acid determination method
US6444432B1 (en) 1997-06-13 2002-09-03 Alan M. Kleinfeld Method of detection of cardiac ischemia using fatty acid binding protein
AU2001278613B2 (en) 2000-08-15 2006-09-07 Discerna Limited Functional protein arrays
EP1728080B1 (en) * 2004-03-22 2014-11-26 FFA Sciences, LLP Development and use of fluorescent probes of unbound analytes
US20060257938A1 (en) * 2005-05-10 2006-11-16 Kleinfeld Alan M Method of screening for drugs that block ligand binding to a lipid binding protein
WO2008060841A2 (en) 2006-10-27 2008-05-22 Ffa Sciences, Llc Use of probes for unbound metabolites
AU2009205935B9 (en) * 2008-01-18 2014-11-13 Ffa Sciences, Llc Development and use of cysteine - labeled fluorescent probes of unbound analytes

Also Published As

Publication number Publication date
CN108051584A (zh) 2018-05-18
JP6847141B2 (ja) 2021-03-24
AU2012300319A2 (en) 2015-06-04
MX2019010563A (es) 2019-10-24
EP2748615B1 (en) 2019-05-01
AU2012300319A1 (en) 2014-02-27
CN104220877A (zh) 2014-12-17
AU2012300319A8 (en) 2017-07-27
ES2733974T3 (es) 2019-12-03
US20170097366A1 (en) 2017-04-06
JP2017104128A (ja) 2017-06-15
US9529003B2 (en) 2016-12-27
JP2014526055A (ja) 2014-10-02
MX2014002051A (es) 2014-09-12
WO2013032953A2 (en) 2013-03-07
CA2846106C (en) 2020-09-01
CN108051584B (zh) 2021-02-12
CN104220877B (zh) 2018-05-15
US20190212346A1 (en) 2019-07-11
AU2019206014A1 (en) 2019-09-26
JP2019146569A (ja) 2019-09-05
CY1122022T1 (el) 2020-10-14
EP2748615A2 (en) 2014-07-02
CA2846106A1 (en) 2013-03-07
AU2017208236B2 (en) 2019-04-18
JP6694403B2 (ja) 2020-05-13
AU2019206014B2 (en) 2021-10-07
EP2748615A4 (en) 2015-07-08
MX380526B (es) 2025-03-12
US11029320B2 (en) 2021-06-08
PT2748615T (pt) 2019-07-22
DK2748615T3 (da) 2019-07-29
JP6104913B2 (ja) 2017-03-29
AU2012300319B2 (en) 2017-07-13
EP3598139A1 (en) 2020-01-22
AU2012300319B8 (en) 2017-07-27
US20150044692A1 (en) 2015-02-12
WO2013032953A3 (en) 2013-08-08
WO2013032953A8 (en) 2014-04-03
US10295551B2 (en) 2019-05-21
AU2017208236A1 (en) 2017-08-10

Similar Documents

Publication Publication Date Title
MX347754B (es) Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar.
WO2013190075A3 (en) Specific biomarkers for hepatocellular carcinoma (hcc)
MX2015006680A (es) Composiciones y metodos para diagnosticar tumores de tiroides.
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
NZ624816A (en) Ratio based biomarkers and methods of use thereof
SI3156422T1 (sl) Človeška protitelesa z visoko afiniteto do PCSK9
BRPI1013688A8 (pt) Proteínas de ligação de il-17.
GB0606776D0 (en) Predictive biomarkers for chronic allograft nephropathy
GB201305223D0 (en) Reflection detection type measurement apparatus for skin autofluorescence
EA201190210A1 (ru) Ингибиторы связывания киназы с белком
ECSP14028523A (es) Moléculas de anticuerpo anti-gcc y uso de las mismas
NZ602840A (en) Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
WO2012094580A3 (en) Compounds that modulate oxidative stress
ATE554389T1 (de) Apex als marker für lungenkrebs
EA201201526A1 (ru) Способы лечения состояний, связанных с il-1b
WO2012102535A3 (ko) 티로신 산화물이 결합된 바이오 물질을 포함하는 단백질 검출용 조성물
DE112009003237A5 (de) Biopsie-instrument zur anreicherung von probenmaterial
EA201690731A1 (ru) Анализ igfbp7, имеющий улучшенную характеристику в биологических образцах
ATE514090T1 (de) Verwendung des proteins satb2 als marker zur unterscheidung kolorektaler karzinome von anderen krebserkrankungen
NZ726748A (en) A method of observing an auto fluorescence image of a cancer related substance through a fluorescence microscope
PE20160657A1 (es) Composiciones y metodos para identificar un riesgo de cancer en un sujeto
BR112015010399A2 (pt) método e kit para a determinação de cobre livre no soro
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
CA2837488C (en) A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid

Legal Events

Date Code Title Description
FG Grant or registration